Zoryve (roflumilast) cream 0.3% — Point32Health
plaque psoriasis
Preferred products
- topical corticosteroids
- topical vitamin D analogs
- topical tazarotene
Initial criteria
- Documented diagnosis of plaque psoriasis
- Patient age ≥ 6 years
- Prescribed by or in consultation with a dermatologist
- Trial and failure or inadequate response to one of the following therapies: medium to very high potency topical corticosteroid, topical vitamin D analog, or topical tazarotene OR contraindication to all of the following: topical corticosteroids, topical vitamin D analog, and topical tazarotene
Reauthorization criteria
- Documentation that the patient has shown improvement on the requested medication
Approval duration
12 months